Lung injury from "liquid ecstasy": a role for coagulation activation?

We describe our second clinical observation of pulmonary injury after a "liquid ecstasy" ingestion/inhalation by a 3-year-old girl. Apart from the deep coma state, a markedly asymmetric pulmonary compromise was recorded. A transient coagulation activation was detected, possibly triggered off by the toxic effect on the lung alveolar-capillary membrane.

[1]  P. Parsons,et al.  Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[2]  S. Elliott.  Nonfatal Instances of Intoxication with γ-Hydroxybutyrate in the United Kingdom , 2004 .

[3]  M. Carraway,et al.  Coagulation and Inflammation in Acute Lung Injury , 2002, Thrombosis and Haemostasis.

[4]  M. Piastra,et al.  Pulmonary oedema caused by “liquid ecstasy” ingestion , 2002, Archives of disease in childhood.

[5]  C. Esmon.  Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation , 2001, Critical care medicine.

[6]  L. Quang,et al.  Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. , 2000, Pediatric emergency care.

[7]  H. Bauchner,et al.  Verve and Jolt: Deadly New Internet Drugs , 2000, Pediatrics.

[8]  B. Bettler,et al.  γ-Hydroxybutyrate is a weak agonist at recombinant GABAB receptors , 1999, Neuropharmacology.

[9]  S. Curry,et al.  Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement". , 1998, The New England journal of medicine.

[10]  S. Suner,et al.  Pediatric gamma hydroxybutyrate intoxication. , 1997, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[11]  S. Borron,et al.  Coma and respiratory arrest after exposure to butyrolactone. , 1996, The Journal of emergency medicine.

[12]  D. Green,et al.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.

[13]  S. Elliott.  Nonfatal instances of intoxication with gamma-hydroxybutyrate in the United Kingdom. , 2004, Therapeutic drug monitoring.

[14]  C. Esmon,et al.  Regulation and functions of the protein C anticoagulant pathway. , 1999, Haematologica.

[15]  B. Bettler,et al.  Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. , 1999, Neuropharmacology.